MIT Technology Review
Eating disorders on the rise; GLP-1s could worsen trends
GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By …
MIT Technology Review
Creating AI value with enterprise context
Across a business, any number of AI platforms, systems, and tools may be at work simultaneously—for example, AI-powered customer platforms, conversational assistants, and workflow and process automation tools. Each one is sophisticated, advanced, and quick to respond. But, when set to work, the outcomes and actions that emerge may be wrong, confuse…
OpenAI Blog
Retell uses OpenAI models to power 100M monthly calls
GPT-6 Astra tops Retell’s voice agent benchmark, while Codex helps it reach a $1.6M annual revenue run rate per employee.